Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

The promise and pitfalls of genomics-driven cancer medicine.

Hofstatter EW, Bale AE.

Virtual Mentor. 2013 Aug 1;15(8):681-6. doi: 10.1001/virtualmentor.2013.15.8.stas1-1308. No abstract available.

PMID:
23937784
2.

Ethical, legal, and social issues related to genomics and cancer research: the impending crisis.

Ellerin BE, Schneider RJ, Stern A, Toniolo PG, Formenti SC.

J Am Coll Radiol. 2005 Nov;2(11):919-26. Review.

PMID:
17411966
3.

Cancer Genomics: Large-Scale Projects Translate into Therapeutic Advances.

Mardis ER, Ladanyi M.

PLoS Med. 2016 Dec 27;13(12):e1002209. doi: 10.1371/journal.pmed.1002209. eCollection 2016 Dec.

4.

The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.

Cloonan N, Waddell N, Grimmond SM.

IDrugs. 2010 Nov;13(11):778-81. Review.

PMID:
21046525
5.

Genomics, personalized medicine and cancer practice.

Dancey J.

Clin Biochem. 2012 Apr;45(6):379-81. doi: 10.1016/j.clinbiochem.2012.03.003. No abstract available.

PMID:
22424082
6.

The challenge and promise of the genomic era.

Sledge GW Jr.

J Clin Oncol. 2012 Jan 10;30(2):203-9. doi: 10.1200/JCO.2011.39.0088. Epub 2011 Dec 12. No abstract available.

PMID:
22162574
7.
8.

Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.

Mousses S, Kiefer J, Von Hoff D, Trent J.

Oncogene. 2008 Dec;27 Suppl 2:S58-66. doi: 10.1038/onc.2009.354. Review.

PMID:
19956181
9.

Personalized cancer genomics: the road map to clinical implementation.

Yousef GM.

Clin Chem. 2012 Apr;58(4):661-3. doi: 10.1373/clinchem.2011.181073. Epub 2012 Feb 9. No abstract available.

10.

Why most gene expression signatures of tumors have not been useful in the clinic.

Koscielny S.

Sci Transl Med. 2010 Jan 13;2(14):14ps2. doi: 10.1126/scitranslmed.3000313.

PMID:
20371465
11.

Genomics and the continuum of cancer care.

McDermott U, Downing JR, Stratton MR.

N Engl J Med. 2011 Jan 27;364(4):340-50. doi: 10.1056/NEJMra0907178. Review. No abstract available.

12.

Cancer genomics: technology, discovery, and translation.

Tran B, Dancey JE, Kamel-Reid S, McPherson JD, Bedard PL, Brown AM, Zhang T, Shaw P, Onetto N, Stein L, Hudson TJ, Neel BG, Siu LL.

J Clin Oncol. 2012 Feb 20;30(6):647-60. doi: 10.1200/JCO.2011.39.2316. Epub 2012 Jan 23. Review. Erratum in: J Clin Oncol. 2012 Apr 1;30(10):1149.

PMID:
22271477
13.

Clinical cancer genomics: how soon is now?

Taylor BS, Ladanyi M.

J Pathol. 2011 Jan;223(2):318-26. doi: 10.1002/path.2794. Epub 2010 Oct 28. Review.

PMID:
21125684
14.

Genetics & genomics: what every oncology nurse needs to know.

McCreery H.

ONS Connect. 2011 Feb;26(2):8-12. No abstract available.

PMID:
21388018
15.

[Research progress in cancer genomics].

Fang FD.

Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):555-7. Review. Chinese. No abstract available.

PMID:
17147129
16.

Gene maps lead medicine down the wrong road.

Pollack R.

Perspect Biol Med. 2002 Winter;45(1):43-5. No abstract available.

PMID:
11796930
17.

Cancer biology and genomics: translating discoveries, transforming pathology.

Ladanyi M, Hogendoorn PC.

J Pathol. 2011 Jan;223(2):99-101. doi: 10.1002/path.2812. Review.

PMID:
21082687
18.
19.

Genomics of smoking exposure and cessation: lessons for cancer prevention and treatment.

Penning TM, Lerman C.

Cancer Prev Res (Phila). 2008 Jul;1(2):80-3. doi: 10.1158/1940-6207.CAPR-08-0047. Epub 2008 Mar 31. No abstract available.

20.

The promise of metabolomics in cancer molecular therapeutics.

Fan TW, Lane AN, Higashi RM.

Curr Opin Mol Ther. 2004 Dec;6(6):584-92. Review.

PMID:
15663322

Supplemental Content

Support Center